Mei‐Lin Tang

机构：Guangdong Medical College, Fudan University, Pudong Medical Center · ORCID：0009-0004-7957-3609

发表论文 39 篇 · 总被引 383 次 · h-index 9

代表论文

• Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone (2020 · Molecules · 被引 27)
• Discovery of First-in-Class TAK1–MKK3 Protein–Protein Interaction (PPI) Inhibitor ( R )-STU104 for the Treatment of Ulcerative Colitis through Modulating TNF-α Production (2022 · Journal of Medicinal Chemistry · 被引 12)
• Novel octapeptide-DTX prodrugs targeting MMP-7 as effective agents for the treatment of colorectal cancer with lower systemic toxicity (2020 · European Journal of Medicinal Chemistry · 被引 12)
• Discovery of Pyridone-Substituted Triazolopyrimidine Dual A 2A /A 1 AR Antagonists for the Treatment of Ischemic Stroke (2022 · ACS Medicinal Chemistry Letters · 被引 8)
• A Concise Approach to N-Substituted Rhodanines through a Base-Assisted One-Pot Coupling and Cyclization Process (2020 · Molecules · 被引 6)
• Sulfoxide-mediated approach to flavones through one-pot Knoevenagel condensation/oxa-Michael addition/sulfoxide elimination process of β-(o-hydroxyaryl)-ketosulfone with arylaldehydes (2022 · Tetrahedron Letters · 被引 5)